Nonspecific (heterologous) protection of neonatal BCG vaccination against hospitalization due to respiratory infection and sepsis

Clinical Infectious Diseases

Volumn 60, Issue 11, 2015, Pages 1611-1619

  De Castro, María Jose ^a   Pardo Seco, Jacobo ^b,c   Martinón Torres, Federico ^a,b  

^a University Hospital of Santiago de Compostela   (Spain)

^b Santiago University Clinical Hospital   (Spain)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

BCG vaccination; children; heterologous effects; nonspecific effects

Indexed keywords

BCG VACCINE;

ADOLESCENT; ARTICLE; BCG VACCINATION; CHILD; CHILDHOOD MORTALITY; COMPARATIVE STUDY; GROUPS BY AGE; HOSPITALIZATION; HUMAN; ICD-9-CM; IMMUNIZATION; INFANT; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEPSIS; SPAIN; VIRAL RESPIRATORY TRACT INFECTION; CROSS PROTECTION; EPIDEMIOLOGY; FEMALE; HETEROLOGOUS IMMUNITY; IMMUNOLOGY; MALE; RESPIRATORY TRACT INFECTIONS; TREATMENT OUTCOME; VACCINATION;

ADOLESCENT; BCG VACCINE; CHILD; CHILD, PRESCHOOL; CROSS PROTECTION; EPIDEMIOLOGIC STUDIES; FEMALE; HOSPITALIZATION; HUMANS; IMMUNITY, HETEROLOGOUS; MALE; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; SEPSIS; SPAIN; TREATMENT OUTCOME; VACCINATION;

EID: 84930408913     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ144     Document Type: Article

References (29)

1. UNICEF Statistics and Monitoring Section and World Health Organization. B summary: A statistical reference containing data through 2011 (The 2013 edition).
2. Colditz GA, Berkey CS, Mosteller F, et al. The efficacy of BCG vaccination of newborns and infants in the prevention of tuberculosis. Metaanalysis of the published literature. Pediatrics 1995; 96(1 pt 1):29-35.
3. Flanagan K, van Crevel R, Curtis N, et al. Heterologous ("Nonspecific") and sex-differential effects of vaccines: epidemiology, clinical trials, and emerging immunologic mechanisms. Clin Infect Dis 2013; 57:283-9.
4. Grange JM, Stanford JL, Stanford CA, et al. Vaccination strategies to reduce the risk of leukaemia and melanoma. J R Soc Med 2003; 96:389-92.
5. Singh M, Das RR, Kumar L, et al. Bacille Calmette-Guérin vaccination is associated with lower prevalence of allergic diseases in Indian children. Am J Rhinol Allergy 2013; 27:e107-12.
6. Vaugelade J, Pinchinat S, Guiella G, et al. Non-specific effects of vaccination on child survival: prospective cohort study in Burkina Faso. BMJ 2004; 329:1309.
7. Garly ML, Martins CL, Balé C, et al. BCG scar and positive tuberculin reaction associated with reduced child mortality: a non-specific beneficial effect of BCG? Vaccine 2003; 21:2782-90.
8. Aaby P, Martins CL, Garly ML, et al. Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial. BMJ 2010; 341:c6495.
9. Steenhuis TJ, van Aalderen WM, Bloksma N, et al. Bacille-Calmette- Guérin vaccination and the development of allergic disease in children: a randomized, prospective, single-blind study. Clin Exp Allergy 2008; 38:79-85.
10. Stensballe LG, Nante E, Jensen IP, et al. Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a beneficial effect of BCG vaccination for girls community based case-control study. Vaccine 2005; 23:1251-7.
11. Krone B, Kölmel KF, Grange JM, et al. Impact of vaccination and infectious diseases on the risk of melanoma-evaluation of an EORTC casecontrol study. Eur J Cancer 2003; 39:2372-8.
12. Villumsen M, Sorup S, Jess T, et al. Risk of lymphoma and leukaemia after bacilli Calmette-Guérin and smallpox vaccination: a Danish case cohort study. Vaccine 2009; 27:6950-8.
13. Kleinnijenhuis J, Quintin J, Preijers F, et al. Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci USA 2012; 109:17537-42.
14. Good P. Permutation tests: a practical guide to resampling methods for testing hypotheses. Springer, 2000.
15. Armitage P, Berry G, Matthews JNS. Statistical Methods in Medical Research. B, Oxford, United Kingdom, 2002.
16. R: A Language and Environment for Statistical Computing. http://www. B-project.org. Accessed January 2015.
17. Elguero E, SImondon KB, Vaugelade J, et al. Non-specific effects of vaccination on child survival? A prospective study in Senegal. Trop Med Int Health 2005; 10:956-60.
18. Moulton LH, Rahmatullah L, Halsey NA, et al. Evaluation of non-specific effects of infant inmunizations on early infant mortality in a southern Indian population. Trop Med Int Health 2005; 10: 947-55.
19. Aaby P, Roth A, Ravn H, et al. Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period? J Infect Dis 2011; 204:245-52.
20. Hollm-Delgado M.G., Stuart E.A., Black R.E.Acute lower respiratory infection among Bacille Calmette-Guérin (BCG)-vaccinated children.Pediatrics 133(1) 2014.
21. Näslund C. Resultats des experiences de vaccination par le BCG poursuivies dans le Norrbotten (Suède) (Septembre 1927-Décembre 1931). B Preventative de Tuberculose, Rapports el Documents (Institut Pasteur, Paris), 1932.
22. Ritz N, Mui M, Balloch A, et al. Non-specific effect of Bacille Calmette- Guérin vaccine on the immune response to routine immunisations. B 2013; 31:3098-103.
23. Ota MO, Vekemans J, Schlegel-Haueter SE, et al. Influence of Mycobacterium bovis bacillus Calmette-Guerin on antibody and cytokine responses to human neonatal vaccination. J Immunol 2002; 168:919-25.
24. Mathurin KS, Martens GW, Kornfeld H, Welsh RM. CD4 T-cellmediated heterologous immunity between mycobacteria and poxviruses. B Virol 2009; 83:3528-39.
25. Lalor MK, Ben-Smith A, Gorak-Stolinska P, et al. Population differences in immune responses to Bacille Calmette Guérin vaccination in infancy. B Infect Dis 2009; 199:795-800.
26. Biering-Sørensen S, Aaby P, Napirna BM, et al. Small randomized trial among low-birth-weight children receiving bacillus Calmette-Guérin vaccination at first health center contact. Pediatr Infect Dis J 2012; 31:306-8.
27. Wynn JL, Scumpia PO, Winfield RD, et al. Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TRL agonists. Blood 2008; 112:1750-8.
28. Tsuji S, Matsumoto M, Takeuchi O, et al. Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette Guérin: involvement of Toll-like receptors. Infect Immun 2000; 68:6883-90.
29. Laayouni H, Calafell F, Bertranpetit J, et al. A genome-wide survey does not show the genetic distinctiveness of Basques. Hum Genet 2010; 127:455-8.